tiprankstipranks
Trending News
More News >
Bioxytran (BIXT)
:BIXT
US Market

Bioxytran (BIXT) Financial Statements

Compare
20 Followers

Bioxytran Financial Overview

Bioxytran's market cap is currently $9.70M. The company's EPS TTM is $-0.017; its P/E ratio is ―; Bioxytran is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -8.29K$ -3.64K$ 0.00$ 0.00
Operating Income$ -2.22M$ -3.82M$ -2.13M$ -4.21M$ -1.27M
EBITDA$ -2.22M$ -3.82M$ -2.13M$ -4.21M$ -1.27M
Net Income$ -2.37M$ -4.28M$ -2.46M$ -4.35M$ -3.75M
Balance Sheet
Cash & Short-Term Investments$ 5.15K$ 26.09K$ 295.40K$ 72.36K$ 41.69K
Total Assets$ 138.69K$ 137.64K$ 370.94K$ 119.29K$ 326.40K
Total Debt$ 1.09M$ 1.93M$ 2.17M$ 2.12M$ 1.61M
Net Debt$ 1.09M$ 1.90M$ 1.87M$ 2.05M$ 1.57M
Total Liabilities$ 1.93M$ 3.25M$ 3.66M$ 3.28M$ 2.27M
Stockholders' Equity$ -1.79M$ -2.43M$ -2.70M$ -2.76M$ -2.83M
Cash Flow
Free Cash Flow$ -83.93K$ -819.68K$ -1.84M$ -1.73M$ -1.11M
Operating Cash Flow$ -55.74K$ -775.38K$ -1.81M$ -1.70M$ -1.10M
Investing Cash Flow$ -28.20K$ -44.30K$ -32.25K$ -36.93K$ -10.00K
Financing Cash Flow$ 63.00K$ 550.36K$ 2.06M$ 1.76M$ 981.05K
Currency in USD

Bioxytran Earnings and Revenue History

Bioxytran Debt to Assets

Bioxytran Cash Flow

Bioxytran Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis